Presidents Budget Submission
Duration: January 3, 2013
to
April 30, 2017
General Issues: Medicare/Medicaid , Aviation/Aircraft/Airlines , Budget/Appropriations , Taxation/Internal Revenue Code , Trade (Domestic & Foreign) , Immigration , Copyright/Patent/Trademark , Health Issues
Spending: about $190,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Michael Lewan CoS, Rep Solarz (88); CoS, Sen Lieberman (89-93 & '12)
Senior Advisor, Sen Lieberman ('12)
CoS, Rep Solarz(88); CoS, Sen Lieberman(89-93)
Senior Advisor, Sen Lieberman (12)
Senior Advisor - Senator Joe Lieberman 2012
Senior Advisor - Senator Joe Lieberman 2012
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2017
The Michael Lewan Company terminated an engagement in which they represented Medtronic on June 29, 2017.
Original Filing: 300881559.xml
Lobbying Issues
Presidents Budget Submission
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on April 11, 2017.
Original Filing: 300863770.xml
Lobbying Issues
Presidents Budget Submission
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on Dec. 23, 2016.
Original Filing: 300843135.xml
Lobbying Issues
HR 1427 & S 804 - Medicare CGM Access Act of 2015
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on Oct. 3, 2016.
Original Filing: 300825067.xml
Lobbying Issues
HR 1427 & S 804 - Medicare CGM Access Act of 2015
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on July 20, 2016.
Original Filing: 300817310.xml
Lobbying Issues
S. 2658 - The Federal Aviation Administration Reauthorization Act of 2016; HR 636 - America's Small Business Tax Relief Act of 2015 relating to air shipment of lithium batteries.
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
Lobbying Issues
HR 1427 & S 804 - Medicare CGM Access Act of 2015
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on April 21, 2016.
Original Filing: 300803887.xml
Lobbying Issues
S. 2658 - The Federal Aviation Administration Reauthorization Act of 2016; HR 636 - America's Small Business Tax Relief Act of 2015 relating to air shipment of lithium batteries.
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
Lobbying Issues
HR 1427 & S 804 - Medicare CGM Access Act of 2015
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
The Michael Lewan Company amended a lobbying report for representation of Medtronic in Q42015 on Jan. 20, 2016.
Original Filing: 300782652.xml
Lobbying Issues
H.R. 1735 - National Defense Authorization Act of 2016 - provisions related to federal contracting limitations
H.R. 3762 Restoring Americans' Healthcare Freedom Reconciliation Act and Issues related to the repeal of the medical device tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax.
S.144 - Protect Medical Innovation Act - provisions related to the medical device tax.
H.R. 2029 - Consolidated Appropriations Act of 2016 - Provisions related to medical device tax delay.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
H.R. 3762, Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the repeal of the medical device tax;
S. 1946, Tax Relief Extension Act as they relate to R+D tax credit.
H.R. 34 the Tax Increase Prevention and Real Estate Investment Act - sections related to expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2015
In Q4, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on Jan. 6, 2016.
Original Filing: 300769359.xml
Lobbying Issues
Issues and provisions related to authorization of H-1B visas.
Issues and provisions related to enhancement of American competitiveness through the encouragement of high-skilled STEM education workers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provided continued support for the Medtronic acquisition of Covidien, which include attention to potential legislation on federal contracting limitations and various tax policy proposals.
S.Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Issues related to repeal of the medical device tax.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Issues related to statutory extension of Trade Promotion Authority.
Issues that promote the competitiveness of the US healthcare sector in international markets.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2015
In Q3, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on Oct. 16, 2015.
Original Filing: 300755317.xml
Lobbying Issues
Issues and provisions related to authorization of H-1B visas.
Issues and provisions related to enhancement of American competitiveness through the encouragement of high-skilled STEM education workers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provided continued support for the Medtronic acquisition of Covidien, which include attention to potential legislation on federal contracting limitations and various tax policy proposals.
S.Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Issues related to repeal of the medical device tax.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Issues related to statutory extension of Trade Promotion Authority.
Issues that promote the competitiveness of the US healthcare sector in international markets.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2015
The Michael Lewan Company amended a lobbying report for representation of Medtronic in Q22015 on July 20, 2015.
Original Filing: 300742636.xml
Lobbying Issues
Issues and provisions related to authorization of H-1B visas.
Issues and provisions related to enhancement of American competitiveness through the encouragement of high-skilled STEM education workers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provided continued support for the Medtronic acquisition of Covidien, which include attention to potential legislation on federal contracting limitations and various tax policy proposals.
S.Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Issues related to repeal of the medical device tax.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Issues related to statutory extension of Trade Promotion Authority.
Issues that promote the competitiveness of the US healthcare sector in international markets.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2015
In Q2, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on July 14, 2015.
Original Filing: 300734220.xml
Lobbying Issues
Issues and provisions related to authorization of H-1B visas.
Issues and provisions related to enhancement of American competitiveness through the encouragement of high-skilled STEM education workers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Con Res - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provided continued support for the Medtronic acquisition of Covidien, which include attention to potential legislation on federal contracting limitations and various tax policy proposals.
S.Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Issues related to repeal of the medical device tax.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Issues related to statutory extension of Trade Promotion Authority.
Issues that promote the competitiveness of the US healthcare sector in international markets.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2015
The Michael Lewan Company amended a lobbying report for representation of Medtronic in Q22015 on July 14, 2015.
Original Filing: 300734242.xml
Lobbying Issues
Issues and provisions related to authorization of H-1B visas.
Issues and provisions related to enhancement of American competitiveness through the encouragement of high-skilled STEM education workers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provided continued support for the Medtronic acquisition of Covidien, which include attention to potential legislation on federal contracting limitations and various tax policy proposals.
S.Con. Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Issues related to repeal of the medical device tax.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Issues related to statutory extension of Trade Promotion Authority.
Issues that promote the competitiveness of the US healthcare sector in international markets.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2015
The Michael Lewan Company amended a lobbying report for representation of Medtronic in Q12015 on July 1, 2015.
Original Filing: 300731167.xml
Lobbying Issues
H.R. 9 - Innovation Act - provisions related to the protection of technology companies from predatory lawsuits. Issues related to trade secrets for provisions related to promoting and protection innovation, competitiveness, and foreign markets.
Issues related to patent reform legislation.
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues and provisions related to authorization of H-1B visas.
Issues and provisions related to enhancement of American competitiveness through the encouragement of high-skilled STEM education.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Con Res - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provided continued support for the Medtronic acquisition of Covidien, which include attention to potential legislation on federal contracting limitations and various tax policy proposals.
Issues related to repeal of the medical device tax.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Issues related to statutory extension of Trade Promotion Authority.
Issues that promote the competitiveness of the US healthcare sector in international markets.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2015
In Q1, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on June 29, 2015.
Original Filing: 300730989.xml
Lobbying Issues
H.R. 9 - Innovation Act - provisions related to the protection of technology companies from predatory lawsuits. Issues related to trade secrets for provisions related to promoting and protection innovation, competitiveness, and foreign markets.
Issues related to patent reform legislation.
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues and provisions related to authorization of H-1B visas.
Issues and provisions related to enhancement of American competitiveness through the encouragement of high-skilled STEM education.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Con Res - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provided continued support for the Medtronic acquisition of Covidien, which include attention to potential legislation on federal contracting limitations and various tax policy proposals.
Issues related to repeal of the medical device tax.
International tax issues including OUS earnings and territorial tax reform proposals.
Issues related to foreign direct investment.
Issues related to the extension of expiring business tax provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
Issues related to statutory extension of Trade Promotion Authority.
Issues that promote the competitiveness of the US healthcare sector in international markets.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2014
In Q4, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on Jan. 20, 2015.
Original Filing: 300702646.xml
Lobbying Issues
Provided continuing support for Medtronic acquisition of Covidien, which included attention to potential legislation on federal contracting limitations and various tax policy proposals.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on Oct. 1, 2014.
Original Filing: 300673305.xml
Lobbying Issues
H.R. 3590 - Patient Protection and Affordability Act (Implementation)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2360, H.R. 4679 - Stop Corporate Inversion Act of 2014 - Information sharing regarding the June 15, 2014 announcement by Medtronic that the company entered into a definitive agreement to acquire healthcare technology and medical supplies provider Covidien
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2014
The Michael Lewan Company amended a lobbying report for representation of Medtronic in Q22014 on July 22, 2014.
Original Filing: 300670098.xml
Lobbying Issues
H.R. 3590 - Patient Protection and Affordability Act (Implementation)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2360, H.R. 4679 - Stop Corporate Inversion Act of 2014 - Information sharing regarding the June 15, 2014 announcement by Medtronic that the company entered into a definitive agreement to acquire healthcare technology and medical supplies provider Covidien
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2014
In Q2, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on July 7, 2014.
Original Filing: 300653796.xml
Lobbying Issues
H.R. 3590 - Patient Protection and Affordability Act (Implementation)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor tax reform
Medical Device Tax
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2014
In Q1, The Michael Lewan Company lobbied for Medtronic , earning $10,000. The report was filed on April 9, 2014.
Original Filing: 300633582.xml
Lobbying Issues
H.R. 3590 - Patient Protection and Affordability Act (Implementation)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor tax reform
Medical Device Tax
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2013
The Michael Lewan Company amended a lobbying report for representation of Medtronic in Q42013 on Jan. 14, 2014.
Original Filing: 300613541.xml
Lobbying Issues
H.R. 3590 - Patient Protection and Affordability Act (Implementation)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor tax reform
Medical Device Tax
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
The Michael Lewan Company amended a lobbying report for representation of Medtronic in Q32013 on Oct. 21, 2013.
Original Filing: 300601764.xml
Lobbying Issues
H.R. 3590 - Patient Protection and Affordability Act (Implementation)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor tax reform
Medical Device Tax
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
In Q3, The Michael Lewan Company lobbied for Medtronic , earning $20,000. The report was filed on Oct. 15, 2013.
Original Filing: 300593775.xml
Lobbying Issues
H.R. 3590 - Patient Protection and Affordability Act (Implementation)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor tax reform
Medical Device Tax
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
In Q2, The Michael Lewan Company lobbied for Medtronic , earning $20,000. The report was filed on July 2, 2013.
Original Filing: 300568954.xml
Lobbying Issues
HR 523 & S 232 Medical Device Access and Innovation Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 169 The Immigration Innovation Act of 2013
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
The Michael Lewan Company filed a lobbying registration on May 8, 2013 to represent Medtronic, effective May 1, 2013.
Original Filing: 300566964.xml
Issue(s) they said they’d lobby about: General healthcare, tax and trade issues. .
1st Quarter, 2013
The Michael Lewan Company terminated an engagement in which they represented Medtronic on April 3, 2013.
Original Filing: 300547117.xml
1st Quarter, 2013
The Michael Lewan Company filed a lobbying registration on Jan. 22, 2013 to represent Medtronic, effective Jan. 3, 2013.
Original Filing: 300543076.xml
Issue(s) they said they’d lobby about: General health, tax and trade issues .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...